Samantha Isaac
Physician Assistant · Vinton, IANPI 1700327665
Payments from drug & device makers
Across 684 payments — averaging $15.82 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$3K
- Amgen$1K
- AstraZeneca$1K
- Pfizer$726
- Boehringer Ingelheim$655
- Lilly USA, LLC$645
- plus $4K from 32 others
What the payments were for
- Food & beverage$10,822100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie(2 entities) | 162 | $2,612 |
| Amgen | 105 | $1,266 |
| AstraZeneca | 39 | $1,009 |
| Pfizer | 46 | $726 |
| Boehringer Ingelheim | 43 | $655 |
| Lilly USA, LLC | 47 | $645 |
| Bayer | 24 | $446 |
| Axsome Therapeutics, Inc. | 15 | $429 |
| Novo Nordisk | 35 | $403 |
| Phathom Pharmaceuticals, Inc. | 11 | $283 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 19 | $234 |
| Mylan Specialty L.p. | 13 | $206 |
| Otsuka America Pharmaceutical, Inc. | 11 | $202 |
| Exact Sciences | 10 | $168 |
| Biohaven Pharmaceutical Holding Company Ltd. | 12 | $160 |
| Johnson & Johnson | 11 | $156 |
| Idorsia Pharmaceuticals US Inc | 10 | $154 |
| Biohaven Pharmaceuticals, Inc. | 10 | $114 |
| Merck | 7 | $105 |
| GSK | 7 | $104 |
| Takeda Pharmaceuticals U.S.A., Inc. | 7 | $95 |
| Amarin Pharma, Inc. | 5 | $83 |
| Esperion Therapeutics, Inc. | 5 | $74 |
| Novartis | 4 | $65 |
| Abbott | 3 | $65 |
| Xeris Pharmaceuticals, Inc. | 4 | $61 |
| Dexcom, Inc. | 2 | $38 |
| Vertex | 2 | $37 |
| Viatris Specialty LLC | 2 | $32 |
| Harmony Biosciences LLC | 1 | $30 |
| Paratek Pharmaceuticals, Inc. | 2 | $29 |
| Genentech USA, Inc. | 3 | $27 |
| Supernus Pharmaceuticals, Inc. | 2 | $27 |
| Radius Health, Inc. | 1 | $18 |
| Inspire Medical Systems, Inc. | 1 | $18 |
| Insulet Corporation | 1 | $17 |
| Medtronic | 1 | $15 |
| Eisai Inc. | 1 | $15 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- AIRSUPRA$126
How this compares
$10,822 in reported general payments places this provider in the 95th percentile of 1,140 physician assistant providers in Iowa.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| OzempicSemaglutide | 78 | $85,868 |
| MounjaroTirzepatide | 77 | $77,784 |
| FarxigaDapagliflozin Propanediol | 68 | $57,713 |
| JardianceEmpagliflozin | 53 | $56,294 |
| RexultiBrexpiprazole | 21 | $34,228 |
| XareltoRivaroxaban | 43 | $32,126 |
| RybelsusSemaglutide | 12 | $31,968 |
| EliquisApixaban | 22 | $22,013 |
| Breztri AerosphereBudesonide/Glycopyr/Formoterol | 36 | $21,506 |
| LinzessLinaclotide | 16 | $20,479 |
| Tresiba Flextouch U-200Insulin Degludec | 19 | $13,876 |
| Trelegy ElliptaFluticasone/Umeclidin/Vilanter | 19 | $12,112 |
| Repatha SureclickEvolocumab | 16 | $11,815 |
| Anoro ElliptaUmeclidinium Brm/Vilanterol Tr | 15 | $6,975 |
| Omnipod 5 Dexg7g6 Pods (Gen 5)Insulin Pump Cart,auto,bt,g6/7 | 11 | $6,618 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Novo NordiskOzempic, Rybelsus | $403 | $117,83690 claims |
| AstraZenecaFarxiga, Breztri Aerosphere | $1,009 | $79,219104 claims |
| Lilly USA, LLCMounjaro | $645 | $77,78477 claims |
| Boehringer IngelheimJardiance | $655 | $56,29453 claims |
| Otsuka America Pharmaceutical, Inc.Rexulti | $202 | $34,22821 claims |
| Johnson & JohnsonXarelto | $156 | $32,12643 claims |
| PfizerEliquis | $726 | $22,01322 claims |
| AbbVieLinzess | $2,612 | $20,47916 claims |
| GSKTrelegy Ellipta, Anoro Ellipta | $104 | $19,08734 claims |
| Esperion Therapeutics, Inc.Nexlizet | $74 | $4,73113 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 1,140 physician assistant providers in Iowa.
Other physician assistant in Vinton
- Jayson GesulgaUrbandale$878K
- Laurie ClairJohnston$293K
- Katherine LemAmes$224K
- Laura CunninghamWest Des Moines$128K
- Michon LeddyClive$73K
- Kyle HawkinsIowa City$42K
- Andrew MetzgerIowa City$37K
- Myrl HolidaIowa City$37K
- Kelly MerchieDavenport$15K
- Kathleen DuffyClive$13K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.